脑胶质瘤患者外周血中Th17、Th22细胞的表达及意义
Expressions and significance of Th17 and Th22 cells in peripheral blood of patients with glioma

DOI: 10.6040/j.issn.1671-7554.0.2015.1101

Keywords: Th17细胞,脑胶质细胞瘤,Th22细胞,白细胞介素-22,
Th17 cells,Th22 cells,Interleukin-22,Glioma

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Wolk K, Witte E, Witte K, et al. Biology of interleukin-22[J]. Semin Immunopathol, 2010, 32(1):17-31.
[2]	Zenewicz LA, Flavell RA. Recent advances in IL-22 biology[J]. Int Immunol, 2011, 23(3):159-163.
[3]	Witte E, Witte K, Warszawska K, et al. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection[J]. Cytokine Growth Factor Rev, 2010, 21(5): 365-379.
[4]	Xie MH, Aggarwal S, Ho WH, et al. Interleukin(IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R[J]. J Biol Chem, 2000, 275(40): 31335-31339.
[5]	Akil H, Abbaci A, Lalloue F, et al. IL22/IL-22R pathway induces cell survival in human glioblastoma cells[J]. PLoS One, 2015, 10(3): e0119872. doi: 10.1371/journal.pone.0119872.
[6]	Wang L, Yi T, Kortylewski M, et al. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway[J]. J Exp Med, 2009, 206(7): 1457-1464.
[7]	Wainwright DA, Sengupta S, Han Y, et al. The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma[J]. PLoS One, 2010, 5(10): e15390. doi: 10.1371/journal.pone.0015390.
[8]	Hu J, Mao Y, Li M, et al. The profile of Th17 subset in glioma[J]. Int Immunopharmacol, 2011, 11(9): 1173-1179.
[9]	Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived inducible factor(IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9[J]. J Immunol, 2000, 164(4):1814-1819.
[10]	Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma[J]. Blood, 2008, 112(2): 362-373.
[11]	Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation[J]. Immunity, 2007, 27(4): 647-659.
[12]	Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011[J]. Neuro Oncol, 2014, 16(Suppl 4): iv1-iv63.
[13]	Rolle CE, Sengupta S, Lesniak MS. Challenges in clinical design of immunotherapy trials for malignant glioma[J]. Neurosurg Clin N Am, 2010, 21(1): 201-214.
[14]	Galea I, Bernardes-Silva M, Forse PA, et al. An antigen-specific pathway for CD8 T cells across the blood-brain barrier[J]. J Exp Med, 2007, 204(9): 2023-2030.
[15]	Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type1 and 2 lineages[J]. Nat Immunol, 2005, 6(11): 1123-1132.
[16]	Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells[J]. Cell, 2006, 126(6): 1121-1133.
[17]	Trifari S, Kaplan CD, Tran EH, et al. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells[J]. Nat Immunol, 2009, 10(8): 864-871.
[18]	Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells[J]. Nat Immunol, 2009, 10(8): 857-863.

Full-Text